The research time span covered by the report is from 2019 to 2030; it provides an overview of the Global Drug Repurposing Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.

The global Drug Repurposing market size in 2023 is 32100.0 million US dollars, and it is expected to be 43683.7 million US dollars by 2030, with a compound annual growth rate of 4.5% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Drug Repurposing market include Algernon Pharmaceuticals, Biovista, Celentyx Ltd, ChemBio Discovery, Inc., and Chord Therapeutics SA. The share of the top 3 players in the Drug Repurposing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Drug Repurposing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Disease-centric accounted for XX% of Drug Repurposing market in 2023. Target-centric share of XX%.
Biologics accounted for XX% of the Drug Repurposing market in 2023. Small Molecule accounts for XX%.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it”s going to evolve in the years to come.

Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, study objectives and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Drug Repurposing market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapters 3-5: Segmented the global Drug Repurposing market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Provide global Drug Repurposing market size and growth by region.
Chapter 7: Analyzes the main companies in the Drug Repurposing industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 8: Analyzes the Drug Repurposing Value Chain, including industrial chain and major downstream buyers.
Chapter 9: The main points and conclusions of the report.
Chapter 10: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey

Player list
Algernon Pharmaceuticals
Biovista
Celentyx Ltd
ChemBio Discovery, Inc.
Chord Therapeutics SA
Excelra
Fios Genomics
Lantern Pharma, Inc.
Novartis AG
Paradigm Biopharmaceuticals Ltd

Types list
Disease-centric
Target-centric
Drug-centric

Application list
Biologics
Small Molecule

Table of Content

1 Study Coverage
1.1 Drug Repurposing Product Introduction
1.2 Global Drug Repurposing Outlook 2019 VS 2024 VS 2030
1.3 United States Drug Repurposing Outlook 2019 VS 2024 VS 2030
1.4 Drug Repurposing Market Size, United States VS Global, 2019-2030
1.4.1 The Market Share of United States Drug Repurposing in Global, 2019-2030
1.4.2 The Growth Rate of Drug Repurposing Market Size, United States VS Global, 2019 VS 2024 VS 2030
1.5 Drug Repurposing Market Dynamics
1.5.1 Drug Repurposing Market Trends
1.5.2 Drug Repurposing Market Drivers
1.5.3 Drug Repurposing Market Challenges
1.5.4 Drug Repurposing Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Drug Repurposing Competitor Landscape by Company
2.1 Global Drug Repurposing Market Size by Company
2.1.1 Top Global Drug Repurposing Player Ranked by Revenue (2024)
2.1.2 Global Drug Repurposing Revenue by Player (2019-2024)
2.2 Global Drug Repurposing Concentration Ratio (CR)
2.2.1 Drug Repurposing Market Concentration Ratio (CR) (2019-2024)
2.2.2 Global Top 3 and Top 6 Largest Players of Drug Repurposing in 2024
2.3 Global Drug Repurposing Business Distribution, Business Type
2.3.1 Global Drug Repurposing Players, Headquarters and Distribution
2.3.2 Players Drug Repurposing Business Type
2.3.3 Date of International Players Enter into Drug Repurposing Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Drug Repurposing Market Size by Company
2.5.1 Top United States Drug Repurposing Player s Ranked by Revenue (2024)
2.5.2 United States Drug Repurposing Revenue by Player (2019-2024)
3 Drug Repurposing Market Segment by Type
3.1 Drug Repurposing Market Segment by Type
3.2 Global Drug Repurposing Market Size by Type
3.3 United States Drug Repurposing Market Size by Type
4 Drug Repurposing by Market Segment Application
4.1 Drug Repurposing Market Segment by Application
4.2 Global Drug Repurposing Market Size by Application
4.3 United States Drug Repurposing Market Size by Application
5 Global Drug Repurposing Market Size by Region
5.1 Global Drug Repurposing Market Size by Region: 2019 VS 2024 VS 2030
5.2 Global Drug Repurposing Market Size in Value by Region (2019-2030)
5.2.1 Global Drug Repurposing Revenue by Region: 2019-2024
5.2.2 Global Drug Repurposing Revenue by Region: 2024-2030
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Drug Repurposing Market Size YoY Growth 2019-2030
6.1.2 North America Drug Repurposing Market Facts & Figures by Country (2019-2030)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Drug Repurposing Market Size YoY Growth 2019-2030
6.2.2 Asia Pacific Drug Repurposing Market Facts & Figures by Country (2019-2030)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Drug Repurposing Market Size YoY Growth 2019-2030
6.3.2 Europe Drug Repurposing Market Facts & Figures by Country (2019-2030)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Drug Repurposing Market Size YoY Growth 2019-2030
6.4.2 Latin America Drug Repurposing Market Facts & Figures by Country (2019-2030)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Drug Repurposing Market Size YoY Growth 2019-2030
6.5.2 Middle East and Africa Drug Repurposing Market Facts & Figures by Country (2019-2030)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Algernon Pharmaceuticals
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 Drug Repurposing Introduction
7.1.4 Algernon Pharmaceuticals Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.1.5 Algernon Pharmaceuticals Recent Development
7.2 Biovista
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 Drug Repurposing Introduction
7.2.4 Biovista Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.2.5 Biovista Recent Development
7.3 Celentyx Ltd
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 Drug Repurposing Introduction
7.3.4 Celentyx Ltd Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.3.5 Celentyx Ltd Recent Development
7.4 ChemBio Discovery, Inc.
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 Drug Repurposing Introduction
7.4.4 ChemBio Discovery, Inc. Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.4.5 ChemBio Discovery, Inc. Recent Development
7.5 Chord Therapeutics SA
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 Drug Repurposing Introduction
7.5.4 Chord Therapeutics SA Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.5.5 Chord Therapeutics SA Recent Development
7.6 Excelra
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 Drug Repurposing Introduction
7.6.4 Excelra Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.6.5 Excelra Recent Development
7.7 Fios Genomics
7.7.1 Company Details
7.7.2 Description and Business Overview
7.7.3 Drug Repurposing Introduction
7.7.4 Fios Genomics Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.7.5 Fios Genomics Recent Development
7.8 Lantern Pharma, Inc.
7.8.1 Company Details
7.8.2 Description and Business Overview
7.8.3 Drug Repurposing Introduction
7.8.4 Lantern Pharma, Inc. Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.8.5 Lantern Pharma, Inc. Recent Development
7.9 Novartis AG
7.9.1 Company Details
7.9.2 Description and Business Overview
7.9.3 Drug Repurposing Introduction
7.9.4 Novartis AG Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.9.5 Novartis AG Recent Development
7.10 Paradigm Biopharmaceuticals Ltd
7.10.1 Company Details
7.10.2 Description and Business Overview
7.10.3 Drug Repurposing Introduction
7.10.4 Paradigm Biopharmaceuticals Ltd Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024)
7.10.5 Paradigm Biopharmaceuticals Ltd Recent Development
8 Value Chain and Sales Channels Analysis
8.1 Drug Repurposing Value Chain Analysis
8.2 Drug Repurposing Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer

List of Tables and Figures

Figure Drug Repurposing Product Picture
Table Global Drug Repurposing Revenue, ($), 2019 VS 2024 VS 2030
Figure Global Drug Repurposing Market Size 2019-2030 ($)
Table United States Drug Repurposing Revenue, ($), 2019 VS 2024 VS 2030
Figure United States Drug Repurposing Market Size 2019-2030 ($)
Figure United States Drug Repurposing Market Share in Global, in Value 2019-2030
Table Drug Repurposing CAGR in Value, United States VS Global, 2019 VS 2024 VS 2030
Table Drug Repurposing Market Trends
Table Drug Repurposing Market Drivers
Table Drug Repurposing Market Challenges
Table Drug Repurposing Market Restraints
Figure Drug Repurposing Report Years Considered
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Top Drug Repurposing Players in Global Market, Ranking by Revenue (2024)
Table Global Drug Repurposing Revenue by Player, ($), 2019-2024
Table Global Drug Repurposing Revenue Share by Player, 2019-2024
Table Global Drug Repurposing Players Market Concentration Ratio (CR5)
Figure The Top 3 and 6 Largest Players of Drug Repurposing in the World: Market Share by Drug Repurposing Revenue in 2024
Table Top Players of Drug Repurposing in Global Market, Headquarters and Distribution
Table Players Drug Repurposing Business Type
Table Date of International Players Enter into Drug Repurposing Market
Table Players Mergers & Acquisitions, Expansion Plans
Table Top Drug Repurposing Players in United States Market, Ranking by Revenue (2024)
Table United States Drug Repurposing Revenue by Player, ($), 2019-2024
Table United States Drug Repurposing Revenue Share by Player, 2019-2024
Table Global Drug Repurposing Revenue by Type: 2024 VS 2030 ($)
Figure Global Drug Repurposing Market Share by Type in 2024 & 2030
Figure Global Drug Repurposing Revenue by Type (2019-2030) & ($)
Figure Global Drug Repurposing Revenue Market Share in Value by Type (2019-2030)
Table United States Drug Repurposing Revenue by Type: 2024 VS 2030 ($)
Figure United States Drug Repurposing Market Share by Type in 2024 & 2030
Figure United States Drug Repurposing Revenue by Type (2019-2030) & ($)
Figure United States Drug Repurposing Revenue Market Share in Value by Type (2019-2030)
Table Global Drug Repurposing Revenue by Application: 2024 VS 2030 ($)
Figure Global Drug Repurposing Market Share by Application in 2024 & 2030
Figure Global Drug Repurposing Revenue by Application (2019-2030) & ($)
Figure Global Drug Repurposing Revenue Market Share in Value by Application (2019-2030)
Table United States Drug Repurposing Revenue by Application: 2024 VS 2030 ($)
Figure United States Drug Repurposing Market Share by Application in 2024 & 2030
Figure United States Drug Repurposing Revenue by Application (2019-2030) & ($)
Figure United States Drug Repurposing Revenue Market Share in Value by Application (2019-2030)
Table Global Drug Repurposing Market Size by Region ($): 2019 VS 2024 VS 2030
Figure Global Drug Repurposing Market Size Market Share by Region: 2019 VS 2024 VS 2030
Table Global Drug Repurposing Revenue by Region (2019-2024) & ($)
Table Global Drug Repurposing Revenue Forecast by Region (2024-2030) & ($)
Table Global Drug Repurposing Revenue Market Share by Region (2019-2030)
Figure North America Drug Repurposing Revenue Growth Rate 2019-2030
Table North America Drug Repurposing Revenue by Country (2019-2030) & ($)
Figure U.S. Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Canada Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Asia Pacific Drug Repurposing Revenue Growth Rate 2019-2030 ($)
Table Asia Pacific Drug Repurposing Revenue by Country (2019-2030) & ($)
Figure China Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Japan Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure South Korea Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure India Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Australia Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Southeast Asia Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Europe Drug Repurposing Revenue Growth Rate 2019-2030 ($)
Table Europe Drug Repurposing Revenue by Country (2019-2030) & ($)
Figure Germany Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure France Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure UK Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Italy Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Russia Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Latin America Drug Repurposing Revenue Growth Rate 2019-2030 ($)
Table Latin America Drug Repurposing Revenue by Country (2019-2030) & ($)
Figure Mexico Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Brazil Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Argentina Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Middle East and Africa Drug Repurposing Revenue Growth Rate 2019-2030 ($)
Table Middle East and Africa Drug Repurposing Revenue by Country (2019-2030) & ($)
Figure Turkey Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure Saudi Arabia Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Figure UAE Drug Repurposing Revenue Growth Rate (2019-2030) & ($)
Table Algernon Pharmaceuticals Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Algernon Pharmaceuticals Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Algernon Pharmaceuticals Recent Development
Table Biovista Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Biovista Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Biovista Recent Development
Table Celentyx Ltd Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Celentyx Ltd Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Celentyx Ltd Recent Development
Table ChemBio Discovery, Inc. Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table ChemBio Discovery, Inc. Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table ChemBio Discovery, Inc. Recent Development
Table Chord Therapeutics SA Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Chord Therapeutics SA Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Chord Therapeutics SA Recent Development
Table Excelra Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Excelra Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Excelra Recent Development
Table Fios Genomics Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Fios Genomics Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Fios Genomics Recent Development
Table Lantern Pharma, Inc. Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Lantern Pharma, Inc. Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Lantern Pharma, Inc. Recent Development
Table Novartis AG Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Novartis AG Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Novartis AG Recent Development
Table Paradigm Biopharmaceuticals Ltd Company Details
Table Description and Business Overview
Table Drug Repurposing Introduction
Table Paradigm Biopharmaceuticals Ltd Drug Repurposing Revenue, Gross, and Gross Margin (2019-2024) (Million USD)
Table Paradigm Biopharmaceuticals Ltd Recent Development
Figure Drug Repurposing Value Chain
Table Major Customers of Drug Repurposing with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report